Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism.


ABSTRACT: β-catenin signaling can be both a physiological and an oncogenic pathway in the liver. It controls compartmentalized gene expression, allowing the liver to ensure its essential metabolic function. It is activated by mutations in 20 to 40% of hepatocellular carcinomas with specific metabolic features. We decipher the molecular determinants of β-catenin-dependent zonal transcription using mice with β-catenin-activated or -inactivated hepatocytes, characterizing in vivo their chromatin occupancy by Tcf4 and β-catenin, their transcriptome and their metabolome. We find that Tcf4 DNA-bindings depend on β-catenin. Tcf4/β-catenin binds Wnt-responsive elements preferentially around β-catenin-induced genes. In contrast, genes repressed by β-catenin bind Tcf4 on Hnf4-responsive elements. β-catenin, Tcf4 and Hnf4α interact, dictating β-catenin transcription which is antagonistic to that elicited by Hnf4α. Finally, we find the drug/bile metabolism pathway to be the one most heavily targeted by β-catenin, partly through xenobiotic nuclear receptors. We conclude that β-catenin patterns the zonal liver together with Tcf4, Hnf4α and xenobiotic nuclear receptors. This network represses lipid metabolism, and exacerbates glutamine, drug and bile metabolism, mirroring hepatocellular carcinomas with β-catenin mutational activation. In vivo liver samples in 4 conditions: Betacat activated (WCE, Tcf4 chipseq, Betacat chipseq, mRNAseq with 2 replicates), Betacat null (WCE, Tcf4 chipseq, mRNAseq with 2 replicates), Betacat control (mRNAseq with 2 replicates), Wild type (mRNAseq with 2 replicates)

ORGANISM(S): Mus musculus

SUBMITTER: Philippe Veber 

PROVIDER: E-GEOD-35213 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications


<h4>Unlabelled</h4>β-catenin signaling can be both a physiological and oncogenic pathway in the liver. It controls compartmentalized gene expression, allowing the liver to ensure its essential metabolic function. It is activated by mutations in 20%-40% of hepatocellular carcinomas (HCCs) with specific metabolic features. We decipher the molecular determinants of β-catenin-dependent zonal transcription using mice with β-catenin-activated or -inactivated hepatocytes, characterizing in vivo their c  ...[more]

Similar Datasets

2011-07-11 | E-GEOD-28788 | biostudies-arrayexpress
2011-11-01 | E-GEOD-28987 | biostudies-arrayexpress
2014-01-18 | GSE35213 | GEO
2012-08-27 | E-GEOD-36388 | biostudies-arrayexpress
2014-03-12 | E-GEOD-53927 | biostudies-arrayexpress
2012-06-15 | E-GEOD-35599 | biostudies-arrayexpress
2014-01-21 | E-GEOD-47192 | biostudies-arrayexpress
2013-06-01 | E-GEOD-35370 | biostudies-arrayexpress
2011-07-10 | E-GEOD-28789 | biostudies-arrayexpress
2015-05-13 | E-GEOD-31170 | biostudies-arrayexpress